Barinthus Biotherapeutics plc (BRNS)
NASDAQ·Healthcare·Biotechnology
$0.70
+0.00%
Mkt Cap $22.95M
Analyst Ratings
No recent rating data.
Price Target (3 analysts)
$3.00
Range $3.00 – $3.00
Implied Upside
+329.6%
Consensus $3.00 vs current $0.70
NASDAQ·Healthcare·Biotechnology
$0.70
+0.00%
Mkt Cap $22.95M
No recent rating data.
Price Target (3 analysts)
$3.00
Range $3.00 – $3.00
+329.6%
Consensus $3.00 vs current $0.70